Recently Updated Guidelines
Guidelines for Treatment of Cancer by Type
-
Anal Carcinoma Version 3.2025
-
Breast Cancer Version 4.2025
-
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Version 3.2025
-
Colon Cancer Version 3.2025
-
Esophageal and Esophagogastric Junction Cancers Version 3.2025
-
Gastric Cancer Version 2.2025
-
Gastrointestinal Stromal Tumors Version 1.2025
-
Merkel Cell Carcinoma Version 2.2025
-
Multiple Myeloma Version 2.2025
-
Myeloid/Lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Gene Fusions Version 2.2025
-
Neuroblastoma Version 1.2025
-
Pediatric Aggressive Mature B-Cell Lymphomas Version 2.2025
-
Primary Cutaneous Lymphomas Version 2.2025
-
Prostate Cancer Version 2.2025
-
Rectal Cancer Version 2.2025
-
Small Bowel Adenocarcinoma Version 3.2025
-
NCCN Guidelines with Evidence Blocks - Anal Carcinoma Version 3.2025
-
NCCN Guidelines with Evidence Blocks - Breast Cancer Version 4.2025
-
NCCN Guidelines with Evidence Blocks - Colon Cancer Version 2.2025
-
NCCN Guidelines with Evidence Blocks - Gastric Cancer Version 2.2025
-
NCCN Guidelines with Evidence Blocks - Multiple Myeloma Version 2.2025
-
NCCN Guidelines with Evidence Blocks - Myeloid/Lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Gene Fusions Version 2.2025
-
NCCN Guidelines with Evidence Blocks - Pediatric Aggressive Mature B-Cell Lymphomas Version 1.2025
-
NCCN Guidelines with Evidence Blocks - Primary Cutaneous Lymphomas Version 2.2025
-
NCCN Guidelines with Evidence Blocks - Rectal Cancer Version 2.2025
-
NCCN Guidelines with Evidence Blocks - Small Bowel Adenocarcinoma Version 3.2025
-
NCCN Guidelines Adaptations - Breast Cancer Version 4.2025 (English - Middle East & North Africa)
Guidelines for Detection, Prevention, & Risk Reduction
Guidelines for Supportive Care
-
Palliative Care Version 2.2025
-
Survivorship Version 1.2025